Status:

RECRUITING

Extracellular Vesicles and Particles (EVP) as Biomarkers of Recurrence in Non-Small Cell Lung Cancer

Lead Sponsor:

Memorial Sloan Kettering Cancer Center

Conditions:

Non-Small Cell Lung Cancer

Eligibility:

All Genders

18+ years

Brief Summary

The purpose of this study is to find out if fluid rinsed from peoples' airways (bronchial washing samples) during routine surgery to remove (resect) their non-small cell lung cancer (NSCLC) tumors con...

Eligibility Criteria

Inclusion

  • All patients ≥ 18 years of age undergoing consideration of surgical resection, including lobar resections, sublobar resections, and pneumonectomies, for primary lung cancer will be eligible.
  • Patients with previously resected disease and/or previous radiation therapy will be considered on a case by case basis.

Exclusion

  • Patients with active infection or pneumonia which may impact exosome makeup
  • Additionally, if at the discretion of the operating surgeon, obtaining bronchial washings would lead to undue morbidity, the patient would be excluded and replaced

Key Trial Info

Start Date :

June 14 2022

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 1 2026

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT05424029

Start Date

June 14 2022

End Date

June 1 2026

Last Update

July 3 2025

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

Memorial Sloan Kettering Basking Ridge (Consent Only)

Basking Ridge, New Jersey, United States, 07920

2

Memorial Sloan Kettering Monmouth (Consent Only)

Middletown, New Jersey, United States, 07748

3

Memorial Sloan Kettering Bergen (Consent Only)

Montvale, New Jersey, United States, 07645

4

Memorial Sloan Kettering Suffolk - Commack (Consent Only)

Commack, New York, United States, 11725

Extracellular Vesicles and Particles (EVP) as Biomarkers of Recurrence in Non-Small Cell Lung Cancer | DecenTrialz